Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis

Brain

Volumn 128, Issue 7, 2005, Pages 1667-1676

  Cepok, Sabine ^a   Rosche, Berit ^a   Grummel, Verena ^a   Vogel, Friederike ^a   Zhou, Dun ^a   Sayn, Joachim ^b   Sommer, Norbert ^b   Hartung, Hans Peter ^a   Hemmer, Bernhard ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

B cells; Cerebrospinal fluid; Multiple sclerosis; Plasma blasts

Indexed keywords

IMMUNOGLOBULIN G;

ACUTE DISEASE; ARTICLE; B LYMPHOCYTE; BLAST CELL; CELL COUNT; CELL KINETICS; CELL POPULATION; CELL TYPE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; HUMAN; IMMUNOGLOBULIN PRODUCTION; INFECTION; MAJOR CLINICAL STUDY; MEMORY CELL; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; BORRELIA INFECTION; BRAIN; CASE CONTROL STUDY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FLOW CYTOMETRY; IMMUNOLOGY; LONGITUDINAL STUDY; PATHOLOGY; VIRUS MENINGITIS;

B-LYMPHOCYTES; BORRELIA INFECTIONS; BRAIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FLOW CYTOMETRY; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MENINGITIS, VIRAL; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; PLASMA CELLS;

EID: 21944448962     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh486     Document Type: Article

References (43)

1. Arce S, Cassese G, Hauser A, Dörner T, Odendahl M, Manz R, et al. The role of long-lived plasma cells in autoimmunity. Immunobiology 2002; 206: 558-62.
2. Archelos JJ, Storch MK, Hartung HP. The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol 2000; 47: 694-706.
3. Baranzini SE, Jeong MC, Butunoi C, Murray RS, Bernard CC, Oksenberg JR. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol 1999; 163: 5133-44.
4. Bergmann CC, Ramakrishna C, Kornacki M, Stohlman SA. Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection. J Immunol 2001; 167: 1575-83.
5. Cassese G, Lindenau S, de Boer B, Arce S, Hauser A, Riemekasten G, et al. Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur J Immunol 2001; 31: 2726-32.
6. Cepok S, Jacobsen M, Schock S, Orner B, Jaekel S, Böddeker I, et al. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 2001; 124: 2169-76.
7. Colombo M, Dono M, Gazzola P, Roncella S, Valetto A, Chiorazzi N, et al. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol 2000; 164: 2782-9.
8. Colombo M, Dono M, Gazzola P, Chiorazzi N, Mancardi G, Ferrarini M. Maintenance of B lymphocyte-related clones in the cerebrospinal fluid of multiple sclerosis patients. Eur J Immunol 2003; 33: 3433-38.
9. Corcione A, Casazza S, Ferretti E, Roncella S, Valetto A, Chiorazzi N, et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci USA 2004; 101: 11064-19.
10. Cross AH, Trotter JL, Lyons J. B cells and antibodies in CNS demyelinating disease. J Neuroimmunol 2001; 112: 1-14.
11. Harada H, Kawano MM, Huang Y, Harada Y, Iwato K, Tanabe O, et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 1993; 81: 2658-63.
12. Hemmer B, Archelos JJ, Hartung HP. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 2002; 3: 291-301.
13. Iszquierdo G, Angulo S, Garcia-Moreno JM, Gamero MA, Navarro G, Gata JM, RUIZ-Pena JL, Paramo MD. Intrathecal IgG synthesis: marker of progression in multiple sclerosis patients. Acta Neurol Scand 2002; 105: 158-63.
14. Jego G, Robillard N, Puthier D, Amiot M, Accard F, Pineau D, et al. Reactive plasmacytosis are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood 1999; 94: 701-12.
15. Rabat EA, Moore DH, Landow H. An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins. J Clin Invest 1942; 21: 571-7.
16. Knopf PM, Harling-Berg CJ, Cserr HF, Basu D, Sirulnick EJ, Nolan SC, et al. Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells. J Immunol 1998; 161: 692-701.
17. Linington C, Bradl M, Lassmann H, Brunner C, Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 1988; 130: 443-54.
18. Luque R, Brieva JA, Moreno A, Manzanal A, Escribano L, Villarrubia J, et al. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients-diagnostic and clinical implications. Clin Exp Immunol 1998; 112:410-8.
19. Magliozzi R, Columba-Cabezas S, Serafini B, Aloisi F. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 2004; 148: 11-23.
20. Manz RA, Radbruch A. Plasma cells for a lifetime? Eur J Immunol 2002; 32: 923-7.
21. Manz RA, Thiel A, Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 1997; 388: 133-4.
22. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiplesclerosis. Ann Neurol 2001; 50: 121-7.
23. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343: 938-52.
24. Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000; 165: 5970-9.
25. Odendahl M, Mei H, Hoyer BF, Jacobi AM, Hansen A, Muehlinghaus G, et al. Generation of migratory antigen-specific plasma blasts and mobilisation of resident plasma cells in a secondary immune response. Blood 2005; 105: 1614-21.
26. Owens GP, Kraus H, Burgoon MP, Smith-Jensen T, Devlin ME, Gilden DH. Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol 1998; 43: 236-43.
27. Owens GP, Ritchie AM, Burgoon MP, Williamson RA, Corboy JR, Gilden DH. Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J Immunol 2003; 171: 2725-33.
28. Ritchie A, Gilden DH, Williamson RA, Burgoon MP, Yu X, Helm K, et al. Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis. J Immunol 2001; 173: 649-56.
29. Pfister HW, Wilske B, Weber K. Lyme borreliosis: basic science and clinical aspects. Lancet 1994; 343: 1013-6.
30. Qin Y, Duquette P, Zhang Y, Talbot P, Poole R, Antel J. Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J Clin Invest 1998; 102: 1045-50.
31. Ramakrishna C, Stohlman SA, Atkinson RD, Shlomchik MJ, Bergmann CC. Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J Immunol 2002; 168: 1204-11.
32. Rastetter W, Molina A, White CA. Rituximab: expanding role in therapy for lymphomas and autoimmune diseases. Annu Rev Med 2004; 55: 477-503.
33. Reiber H. Cerebrospinal fluid - physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler 1998; 4: 99-107.
34. Saiz A, Carreras E, Berenguer J, Berenguer J, Yagüe J, Martínez C, et al. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS. Neurology 2001; 56: 1084-9.
35. Slifka MK, Matloubian M, Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol 1995; 69: 1895-902.
36. Steinman L. Multiple sclerosis: a two-stage disease. Nat Immunol 2001; 2: 762-4.
37. Tarte K, De Vos J, Thykjaer T, et al. Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts. Blood 2002; 100: 1113-22.
38. Tschen SI, Bergmann CC, Ramakrishna C, Morales S, Atkinson R, Stohlman SA. Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis. J Immunol 2002; 168: 2922-9.
39. Villar LM, Masjuan J, Gonzalez-Porque P, Plaza J, Sádaba MC, Roldán E, et al. Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS. Neurology 2002; 59: 555-9.
40. Villar LM, Masjuan J, Gonzalez-Porque P, Plaza J, Sadaba MC, Roldan E, et al. Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis. Ann Neurol 2003; 53: 222-6.
41. Walsh MJ, Tourtellotte WW. Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis. J Exp Med 1986; 163: 41-53.
42. Wehr C, Eibel H, Masilamani M, Illges H, Schlesier M, Peter HH, et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol 2004; 113: 161-71.
43. Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999; 46: 878-86.